The carboxy-terminal region of CD5 is required for c-CBL mediated TCR signaling downmodulation in thymocytes

Biochemical and Biophysical Research Communications

Volumn 432, Issue 1, 2013, Pages 52-59

  Roa, Nelly S ^a,d   Ordoñez Rueda, Diana ^a   Chávez Rios, Jesús R ^a   Raman, Chander ^b   García Zepeda, Eduardo A ^a   Lozano, Francisco ^c   Soldevila, Gloria ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b The University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

^d PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

Author keywords

C Cbl; CD5; Downmodulation; TCR; Thymocyte

Indexed keywords

AMINO ACID; CBL PROTEIN; CD3 ANTIGEN; CD5 ANTIGEN; TOLL LIKE RECEPTOR; VAV PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; THYMOCYTE; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD5; CELLS, CULTURED; DOWN-REGULATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTORS, ANTIGEN, T-CELL; SEQUENCE DELETION; SIGNAL TRANSDUCTION; THYMOCYTES;

EID: 84875371177     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.086     Document Type: Article

References (24)

1. Lozano F., Simarro M., Calvo J., Vila J.M., Padilla O., Bowen M.A., Campbell K.S. CD5 signal transduction: positive or negative modulation of antigen receptor signaling. Crit. Rev. Immunol. 2000, 20:347-358.
2. Soldevila G., Raman C., Lozano F. The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease. Curr. Opin. Immunol. 2011, 23:310-318.
3. Azzam H.S., DeJarnette J.B., Huang K., Emmons R., Park C.S., Sommers C.L., El-Khoury D., Shores E.W., Love P.E. Fine tuning of TCR signaling by CD5. J. Immunol. 2001, 166:5464-5472.
4. Ordonez-Rueda D., Lozano F., Sarukhan A., Raman C., Garcia-Zepeda E.A., Soldevila G. Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling. Eur. J. Immunol. 2009, 39:2233-2247.
5. Perez-Villar J.J., Whitney G.S., Bowen M.A., Hewgill D.H., Aruffo A.A., Kanner S.B. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol. Cell. Biol. 1999, 19:2903-2912.
6. Gary-Gouy H., Harriague J., Dalloul A., Donnadieu E., Bismuth G. CD5-negative regulation of B cell receptor signaling pathways originates from tyrosine residue Y429 outside an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 2002, 168:232-239.
7. Bamberger M., Santos A.M., Goncalves C.M., Oliveira M.I., James J.R., Moreira A., Lozano F., Davis S.J., Carmo A.M. A new pathway of CD5 glycoprotein-mediated T cell inhibition dependent on inhibitory phosphorylation of Fyn kinase. J. Biol. Chem. 2011, 286:30324-30336.
8. Thien C.B., Langdon W.Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2001, 2:294-307.
9. Demydenko D. C-Cbl mediated ubiquitylation and regulation of cell surface exposure of CD5. Biochem. Biophys. Res. Commun. 2010, 392:500-504.
10. Naramura M., Kole H.K., Hu R.J., Gu H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl. Acad. Sci. USA 1998, 95:15547-15552.
11. Dennehy K.M., Broszeit R., Ferris W.F., Beyers A.D. Thymocyte activation induces the association of the proto-oncoprotein c-cbl and ras GTPase-activating protein with CD5. Eur. J. Immunol. 1998, 28:1617-1625.
12. Vila J.M., Calvo J., Places L., Padilla O., Arman M., Gimferrer I., Aussel C., Vives J., Lozano F. Role of two conserved cytoplasmic threonine residues (T410 and T412) in CD5 signaling. J. Immunol. 2001, 166:396-402.
13. Calvo J., Vilda J.M., Places L., Simarro M., Padilla O., Andreu D., Campbell K.S., Aussel C., Lozano F. Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II. J. Immunol. 1998, 161:6022-6029.
14. Azzam H.S., Grinberg A., Lui K., Shen H., Shores E.W., Love P.E. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 1998, 188:2301-2311.
15. Burgess K.E., Yamamoto M., Prasad K.V., Rudd C.E. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn. Proc. Natl. Acad. Sci. USA 1992, 89:9311-9315.
16. Vila J.M., Gimferrer I., Padilla O., Arman M., Places L., Simarro M., Vives J., Lozano F. Residues Y429 and Y463 of the human CD5 are targeted by protein tyrosine kinases. Eur. J. Immunol. 2001, 31:1191-1198.
17. Liu Y.C., Altman A. Cbl: complex formation and functional implications. Cell. Signal. 1998, 10:377-385.
18. Dennehy K.M., Ferris W.F., Veenstra H., Zuckerman L.A., Killeen N., Beyers A.D. Determination of the tyrosine phosphorylation sites in the T cell transmembrane glycoprotein CD5. Int. Immunol. 2001, 13:149-156.
19. Dennehy K.M., Broszeit R., Garnett D., Durrheim G.A., Spruyt L.L., Beyers A.D. Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp 120 with CD5. Eur. J. Immunol. 1997, 27:679-686.
20. Gary-Gouy H., Lang V., Sarun S., Boumsell L., Bismuth G. In vivo association of CD5 with tyrosine-phosphorylated ZAP-70 and p21 phospho-zeta molecules in human CD3+ thymocytes. J. Immunol. 1997, 159:3739-3747.
21. Stefanova I., Hemmer B., Vergelli M., Martin R., Biddison W.E., Germain R.N. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol. 2003, 4:248-254.
22. Marengere L.E., Mirtsos C., Kozieradzki I., Veillette A., Mak T.W., Penninger J.M. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. J. Immunol. 1997, 159:70-76.
23. Miura-Shimura Y., Duan L., Rao N.L., Reddi A.L., Shimura H., Rottapel R., Druker B.J., Tsygankov A., Band V., Band H. Cbl-mediated ubiquitinylation and negative regulation of Vav. J. Biol. Chem. 2003, 278:38495-38504.
24. Gringhuis S.I., de Leij L.F., Coffer P.J., Vellenga E. Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes. Mol. Cell. Biol. 1998, 18:1725-1735.